LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q1)Oct 31, 2024 | (FY)Jul 31, 2024 | (Q4)Jul 31, 2024 | (Q3)Apr 30, 2024 | (Q2)Jan 31, 2024 | (Q1)Oct 31, 2023 | (FY)Jul 31, 2023 | (Q4)Jul 31, 2023 | (Q3)Apr 30, 2023 | (Q2)Jan 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -1.07%1.51B | 17.29%3.26B | 23.81%512.7M | 22.40%528.9M | -0.66%690M | 23.39%1.53B | 39.95%2.78B | -20.93%414.1M | 10.94%432.1M | 43.93%694.6M |
Net income from continuing operations | 80.59%350.7M | 486.22%2.58B | 57.09%357.7M | 158.63%278.8M | 1,974.70%1.75B | 871.00%194.2M | 264.68%439.7M | 6,800.00%227.7M | 247.27%107.8M | 190.05%84.2M |
Operating gains losses | 29.03%16M | 10.82%55.3M | 10.61%14.6M | 20.66%14.6M | 9.60%13.7M | 2.48%12.4M | -8.27%49.9M | -21.89%13.2M | -2.42%12.1M | 0.81%12.5M |
Depreciation and amortization | 30.48%83.9M | 0.39%283.3M | 9.81%76.1M | 2.77%74.3M | -1.86%68.6M | -9.05%64.3M | -0.14%282.2M | -4.41%69.3M | 1.26%72.3M | 0.29%69.9M |
Deferred tax | -45,700.00%-137.4M | -16,369.60%-2.03B | -3,091.67%-215.4M | -4,635.71%-127M | ---1.69B | ---300K | 503.23%12.5M | --7.2M | --2.8M | ---- |
Other non cash items | 10.05%117.2M | 7.00%449.5M | 3.83%121.9M | 7.66%111.1M | 9.24%110M | 7.79%106.5M | 13.76%420.1M | 14.20%117.4M | 13.53%103.2M | 14.56%100.7M |
Change In working capital | -10.39%799.9M | 65.27%910.3M | 62.08%-97.5M | 39.49%-70.8M | 18.10%186M | 16.31%892.6M | 5.13%550.8M | -389.85%-257.1M | -412.00%-117M | 14.71%157.5M |
-Change in receivables | 48.66%1.5B | 3.66%-1.02B | 4.89%-1.36B | 54.14%-188.5M | -323.09%-481.9M | 12.85%1.01B | -13.61%-1.06B | -53.02%-1.43B | -42.51%-411M | 18.70%-113.9M |
-Change in prepaid assets | -106.67%-3.6M | 50.44%-134.1M | -79.15%-181.3M | 101.43%1.3M | 83.70%-8.1M | 288.15%54M | -146.00%-270.6M | -811.71%-101.2M | -250.00%-91M | -49,600.00%-49.7M |
-Change in payables and accrued expense | 21.39%-197.4M | 3,421.70%373.3M | 35.38%331.4M | -102.85%-106.9M | 902.26%399.9M | -13.41%-251.1M | -80.66%10.6M | 147.52%244.8M | -210.71%-52.7M | -46.01%39.9M |
-Change in other working capital | -696.27%-495.5M | -9.55%1.69B | 8.13%1.11B | -48.98%223.3M | -1.81%276.1M | -33.78%83.1M | 23.73%1.87B | 9.92%1.03B | 43.84%437.7M | 38.11%281.2M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -1.07%1.51B | 17.29%3.26B | 23.81%512.7M | 22.40%528.9M | -0.66%690M | 23.39%1.53B | 39.95%2.78B | -20.93%414.1M | 10.94%432.1M | 43.93%694.6M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -321.55%-543.8M | 25.76%-1.51B | -146.47%-168.5M | 28.67%113.1M | -13.83%-1.33B | 90.23%-129M | -117.89%-2.03B | 176.81%362.6M | 104.90%87.9M | -324.54%-1.16B |
Net PPE purchase and sale | -19.84%-44.1M | -7.18%-156.8M | -27.42%-47.4M | -19.87%-37.4M | 8.09%-35.2M | 7.07%-36.8M | 24.12%-146.3M | 5.10%-37.2M | 18.54%-31.2M | 52.54%-38.3M |
Net business purchase and sale | ---500M | -198.58%-610.6M | --0 | --0 | ---610.6M | --0 | -452.70%-204.5M | --0 | ---18.9M | ---- |
Net investment purchase and sale | 100.33%300K | 55.88%-742.5M | -130.29%-121.1M | 9.06%150.5M | 27.74%-679.7M | 92.80%-92.2M | -139.20%-1.68B | 196.73%399.8M | 69.95%138M | -385.85%-940.6M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -321.55%-543.8M | 25.76%-1.51B | -146.47%-168.5M | 28.67%113.1M | -13.83%-1.33B | 90.23%-129M | -117.89%-2.03B | 176.81%362.6M | 104.90%87.9M | -324.54%-1.16B |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -425.60%-219.7M | 22.20%-1.34B | 89.03%-179.3M | -918.56%-1.05B | 71.05%-72.6M | -234.41%-41.8M | -114.02%-1.73B | -362.98%-1.63B | 93.36%128.2M | 55.09%-250.8M |
Net issuance payments of debt | -593.48%-319M | 38.91%-1.03B | 88.20%-199.6M | ---661.8M | ---126.3M | ---46M | -281,900.00%-1.69B | ---1.69B | --0 | --0 |
Net common stock issuance | --0 | -107.81%-566.7M | --0 | ---500M | --0 | -193.83%-66.7M | 69.44%-272.7M | --0 | --0 | 54.55%-250M |
Proceeds from stock option exercised by employees | 39.70%120.7M | 9.70%283.9M | -59.73%24.2M | -11.13%115.8M | 8,114.29%57.5M | 27.62%86.4M | 89.46%258.8M | 19,933.33%60.1M | 68.13%130.3M | 600.00%700K |
Net other financing activities | -38.06%-21.4M | -30.39%-26.6M | -34.48%-3.9M | -61.90%-3.4M | -153.33%-3.8M | -11.51%-15.5M | 59.44%-20.4M | 72.38%-2.9M | 81.25%-2.1M | 82.56%-1.5M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -425.60%-219.7M | 22.20%-1.34B | 89.03%-179.3M | -918.56%-1.05B | 71.05%-72.6M | -234.41%-41.8M | -114.02%-1.73B | -362.98%-1.63B | 93.36%128.2M | 55.09%-250.8M |
Net cash flow | ||||||||||
Beginning cash position | 35.42%1.55B | -46.24%1.14B | -30.92%1.38B | 32.33%1.79B | 20.48%2.5B | -46.24%1.14B | 13.02%2.12B | -17.56%2B | -29.86%1.35B | -9.00%2.07B |
Current changes in cash | -44.95%746.1M | 141.18%404.6M | 119.22%164.9M | -162.85%-407.4M | 1.75%-708.1M | 2,706.15%1.36B | -501.55%-982.6M | -184.61%-858.1M | 29.98%648.2M | -105.80%-720.7M |
End cash Position | -8.19%2.29B | 35.42%1.55B | 35.42%1.55B | -30.92%1.38B | 32.33%1.79B | 20.48%2.5B | -46.24%1.14B | -46.24%1.14B | -17.56%2B | -29.86%1.35B |
Free cash flow | -1.59%1.47B | 17.85%3.1B | 23.45%465.3M | 22.60%491.5M | -0.23%654.8M | 24.40%1.49B | 46.84%2.63B | -22.21%376.9M | 14.15%400.9M | 63.30%656.3M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |